# Dengue virus infection: potential applications of "Omics" based approaches

## TL;DR

This paper reviews how 'Omics' approaches can help understand dengue progression and identify biomarkers for better treatment and prevention.

## Contribution

The paper highlights the potential of 'Omics' strategies for biomarker discovery in dengue, aiming to improve precision medicine.

## Key findings

- Differentially expressed genes, proteins, and metabolites may reveal mechanisms behind dengue progression.
- Omics-based biomarkers could aid in disease surveillance and personalized treatment evaluation.
- Current inconsistencies in dengue pathophysiology studies emphasize the need for further research.

## Abstract

Dengue, caused by the dengue virus (DENV), a member of the flavivirus family, continues to pose a significant threat to populations
worldwide, despite advances in technology. Nearly half of the global population is at risk of contracting the disease, ranging from mild
dengue fever (DF) to severe dengue hemorrhagic fever (DHF) and Dengue Shock Syndrome (DSS). The precise mechanisms underlying the
progression of DF to DHF and DSS remain unclear and the presence of various DENV serotypes exacerbates this situation. Urbanization and
climate change are expected to affect dengue epidemiology, potentially increasing the frequency and intensity of outbreaks. This review
aims to consolidate the current knowledge on the biological characteristics, pathogenesis and application of "Omics" based strategies
for biomarker discovery for precision medicine. Although the precise mechanisms behind the progression from DF to DHF/DSS are not fully
understood, hypotheses include immune over-activation, cytokine storms and antibody-dependent enhancement. Studies of comorbid
conditions have shown no significant association with the development of DHF/DSS in patients with diabetes, hypertension, or other
chronic diseases. Despite the far-reaching and intricate nature of dengue, the inconsistencies found in clinical pathophysiological
studies underscore the need for additional research aimed at elucidating the pathogenesis of DHF/DSS and devising effective preventive
measures. Identifying the differentially expressed genes, proteins and metabolites in DF, DHF and DSS may enrich our understanding of
the mechanisms underlying their pathogenesis. Moreover, these differentially regulated pathways may serve as novel therapeutic targets.
These biomarkers may also be utilized for disease surveillance and the evaluation of the efficacy of therapeutic interventions for
personalized treatment. Continuous research is essential to gain deeper insights into the mechanisms and progression of dengue fever and
to formulate more effective prevention and control strategies. A multidisciplinary approach is vital for comprehending dengue virus
pathogenesis, identifying risk factors and creating targeted interventions, particularly through biomarker discovery using "Omics"
approaches.